GlaxoSmithKlineThe Impact of Medicines: Sustainability in Environment, Health and Safety Report 2002
Reporting Front PageDownloads
EHS 2002 home

About this report

Executive statements

Framework

EHS and EHM vision

Environment, health and safety policy

Planning
The EHS Plan for Excellence
Targets

Organisation

Management systems

Programmes

Audit

Stakeholder communication

Reward and recognition

Issues

Performance

Verification statement

Index

Targets
Previous
Next
 
 
Jonathan Box "US manufacturing operations are heavily regulated but our approach to EHS often exceeds regulatory requirements. This reflects our comprehensive understanding of the EHS risks of our business and our ethical commitment to protecting employees, the community and the environment. In addition to being ethical, this makes business sense because it means we can reduce our costs to deliver a higher quality product more efficiently." Jonathan Box, Senior Vice President, North America Supply, Global Manufacturing and Supply

GlaxoSmithKline has set targets for improving environment, health and safety performance to be reached by the end of 2005, starting from a baseline set in 2001. These improvement targets are an integral part of the EHS Plan for Excellence.

2002 Progress To Targets
Injury And Illness - Lost time injury and illness (LT11) rate
Resource Consumption -  Energy consumption
Ozone-Depletion Potential Resource Consumption - Total water consumption
Refrigeration and other ancillary process-related CFC-11 equivalent emissions
Ozone-Depletion Potential -  Production processes-related CFC-11 equivalent emissions
Photochemical Ozone-Creation Potential - Total volatile organic compound (VOC) emissions
Greenhouse Gases/Global Warming Potential - CO2 equivalent emissions from energy-consuming sources
Wastewater Quality - Chemical oxygen demand (COD) of effluent
Waste Generation And Management - Hazardous waste disposed
Waste Generation And Management - Non-hazardous waste disposed
Waste Generation And Management - Hazardous and non-hazardous waste recycled
Diagram key

Targets are based on practical operational improvement plans and forecasts. All GSK manufacturing operations contributed information about environment, health and safety improvement plans and forecasts. The resulting proposals for company targets were compared with benchmarking information and closely reviewed by environment, health and safety professionals, senior managers and management teams throughout the business.

Each GSK operation has improvement targets based on its own unique EHS profile and includes identified local projects so that site resources can focus on areas of greatest potential impact. Sites with the largest impact have the most aggressive reduction targets, while sites with smaller impact have continuous improvement targets. In this way each operation has targets, tailored to its impact, that should result in GSK achieving the overall company targets.



Previous

Next


Top


EHS 2002 Home | Reporting Front Page | Downloads | Main Site

 
Updated July 21, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement